甲氧氯普胺诱导性腺功能减退男性释放生长激素。
Metoclopramide induced growth hormone release in hypogonadal males.
作者信息
Cohen H N, Hay I D, Beastall G H, Thomson J A
出版信息
Clin Endocrinol (Oxf). 1979 Jul;11(1):95-7. doi: 10.1111/j.1365-2265.1979.tb03051.x.
The growth hormone (GH) response to 10 mg intravenous metoclopramide (MCP) ('Maxolon'--Beecham Laboratories) was determined in ten hypogonadal adult males. All the subjects responded with a peak growth hormone level greater than 14 mU/l within 1 hour of administration of MCP. Seven normal adult males did not respond to MCP administration. It is concluded that MCP stimulation may be a useful test for both prolactin and growth hormone reserve in hypogonadal males.
在10名性腺功能减退的成年男性中测定了生长激素（GH）对10毫克静脉注射甲氧氯普胺（MCP，“胃复安”——比彻姆实验室）的反应。所有受试者在注射MCP后1小时内生长激素水平峰值均超过14 mU/l。7名正常成年男性对注射MCP无反应。结论是，MCP刺激试验可能是评估性腺功能减退男性催乳素和生长激素储备的一项有用检测。
Zotero 插件